PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy
Conditions: HNSCC; Radiotherapy; PD-1 Interventions: Drug: PD-1inhibitor; Radiation: concurrent chemoradiotherapy Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; First People's Hospital of Foshan; First Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital& Institute of Guangzhou Medical University; Affiliated Cancer Hospital of Shantou University Medical College Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | HNSCC | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Research